🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
161.20
+1.77 (1.11%)
At close: Nov 20, 2026, 4:00 PM EST
165.79
+4.59 (2.85%)
After-hours: Nov 20, 2026, 7:58 PM EST

Revolution Medicines Stock Forecast

Stock Price Forecast

According to 25 analysts polled by S&P Global, Revolution Medicines stock has a consensus rating of "Strong Buy" and an average price target of $274.68. The average 1-year stock price forecast is 70.40% higher than the current stock price, while the lowest is $179 (+11.04%) and the highest is $350 (+117.12%).

Price Target: $274.68 (+70.40%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$179$274.68$271.5$350
Change+11.04%+70.40%+68.42%+117.12%

Analyst Ratings

The average analyst rating for Revolution Medicines stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy171717171919
Buy444555
Hold111111
Sell000000
Strong Sell000000
Total222222232525

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bernstein
Bernstein
Hold
Maintains
$179
HoldMaintains$179+11.04%Nov 20, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$230
BuyMaintains$230+42.68%Nov 20, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$350
BuyReiterates$350+117.12%Nov 17, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$272 → $247
BuyMaintains$272 → $247+53.23%Nov 13, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
$274
BuyMaintains$274+69.98%Nov 13, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
613.36M
Revenue Next Year
2.05B
from 613.36M
Increased by 233.69%
EPS This Year
-8.26
from -5.95
EPS Next Year
-3.07
from -8.26
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
29.39M35.38M11.58M--613.36M
Gross Profit
-157.56M-217.69M-407.86M-592.23M-987.33M548.31M
Gross Margin
-536.09%-615.30%-3,522.14%--89.39%
Operating Income
-188.01M-258.28M-475.99M-689.52M-1.18B-1.57B
Net Income
-187.09M-248.71M-436.37M-600.09M-1.13B-1.77B
EPS
-----5.95-8.26
Free Cash Flow
-----913.73M-1.30B
No. Analysts
-----21
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High832.6M
Avg613.4M
Low377.1M

Revenue Growth

Revenue Growth20272028
High
450.1%
Avg
233.7%
Low
24.1%

EPS Forecast

EPS202620272028
High-7.18
Avg-8.26
Low-9.51

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-